Metraipolis › archive › dc_af171b9cc2fe

Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV/syphilis rapid diagnostic tests in eleven high… — Europe PMC PMID:34411167

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34411167
DOI
10.1371/journal.pone.0256400
License (as archived)
CC0-1.0
Archived
2026-11-03T06:16:06.597Z
SHA-256 of the archived text
b635be95895a12f7204471f24303b9ddaf93a7ad29ff93cbe00a4c887387897d
Stable URL of this page
https://metraipolis.com/documento/dc_af171b9cc2fe

How to cite

Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV/syphilis rapid diagnostic tests in eleven high… — Europe PMC PMID:34411167 — Europe PMC (en), https://europepmc.org/article/MED/34411167 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_af171b9cc2fe (Metraipolis archive dc_af171b9cc2fe, sha256 b635be95895a12f7204471f24303b9ddaf93a7ad29ff93cbe00a4c887387897d)
BibTeX
@misc{dcaf171b9cc2fe,
  title = {Estimation of benzathine penicillin G demand for congenital syphilis elimination with adoption of dual HIV/syphilis rapid diagnostic tests in eleven high… — Europe PMC PMID:34411167},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34411167},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_af171b9cc2fe; sha256 b635be95895a12f7204471f24303b9ddaf93a7ad29ff93cbe00a4c887387897d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34411167. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: WHO recommends use of rapid dual HIV/syphilis tests for screening pregnant women (PW) during antenatal care to prevent mother-to-child transmission. Scale-up of testing implies a need to accurately forecast and procure benzathine penicillin (BPG) to treat the additionally identified PW with syphilis. Methods: Country-reported ANC coverage, PW syphilis screening and treatment coverage values in 2019 were scaled linearly to EMTCT targets by 2030 (constant increasing slope from 2019 figures to 95% in 2030) for 11 focus countries. Antenatal syphilis screening coverage was substituted with HIV screening coverage to estimate potential contribution of rapid dual HIV/syphilis tests in identifying additional PW with syphilis. BPG demand was calculated for 2019-2030 accordingly. Results: The estimated demand for BPG (in 2.4 million unit vials) using current maternal syphilis prevalence and treatment coverage will increase from a baseline of 414,459 doses in 2019 to 683,067 doses (+65%) in 2021 assuming immediate replacement of single HIV test kits with rapid dual HIV/syphilis tests for these 11 countries. Continued scale up of syphilis screening and treatment coverage to reach elimination coverage of 95% will result in an estimated demand increase of 160%, (663,969 doses) from 2019 baseline for a total demand of 1,078,428 BPG doses by 2030. Conclusions: Demand for BPG will increase following adoption of rapid dual HIV/syphilis test kits due to increases in maternal diagnoses of syphilis. To eliminate congenital syphilis, MNCH clinical programs will need to synergize with disease surveillance programs to accurately forecast BPG demand with scale up of antenatal syphilis screening to ensure adequate treatment is available for pregnant women diagnosed with syphilis.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-08-19).
Identificativi: PMID 34411167 · PMCID PMC8376004 · DOI 10.1371/journal.pone.0256400.
Descrittori MeSH principali: Syphilis, Congenital; Pregnancy Complications, Infectious; HIV Infections; Infectious Disease Transmission, Vertical; Penicillin G Benzathine.
Pagina: https://europepmc.org/article/MED/34411167 — https://doi.org/10.1371/journal.pone.0256400. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-03T06:07:59.325Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.